Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Executives Buy Around $5M Of 3 Penny Stocks


US stocks closed mixed on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Black Diamond Therapeutics

  • The Trade: Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) 10% owner BB Biotech Ag acquired a total of 300,000 shares at an average price of $3.27. To acquire these shares, it cost $980.58 thousand.
  • What’s Happening: Black Diamond Therapeutics recently said first patient was dosed in Phase 1 study of BDTX-1535, a masterkey inhibitor of EGFR for the treatment of glioblastoma and non-small cell lung cancer.
  • What Black Diamond Therapeutics Does: Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies.

Inozyme Pharma

  • The Trade: Inozyme Pharma, Inc. (NASDAQ:INZY) Director Pivotal bioVenture Partners Fund I U.G.P., Ltd acquired a total of 1,070,000 shares at an average price of $3.69. The insider spent around $3.95 million to buy those shares.
  • What’s Happening: The company recently announced an underwritten offering of 16,276,987 shares of its common stock at $3.69 per share for gross proceeds of $73 million.
  • What Inozyme Pharma Does: Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.

Also check this: Insiders Buy More Than $15M Of 3 Stocks

Don’t forget to check out our premarket coverage here .

Societal CDMO

  • The Trade: Societal CDMO, Inc. (NASDAQ:SCTL) 10% owner AWM Investment Company Inc acquired a total of 27,700 shares at an average price of $1.55. To acquire these shares, it cost around $43.03 thousand.
  • What’s Happening: The company recently announced the addition of new employees to fill open roles throughout the organization.
  • What Societal CDMO Does: Societal CDMO, Inc is a contract development and manufacturing organization.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
From analysis to the latest developments in health, read the most diverse news in one place.
Already a member? Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.